The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

 
Web www.patentalert.com

< Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

> Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

> Compounds for the treatment of hepatitis C
~ 00514